ArticleDermatology and therapy2024

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations.

Melinda J Gooderham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.